Prevalence of hypercholesterolemia in Nigeria: a systematic review and meta-analysis by Adeloye, D et al.
Article
Prevalence of hypercholesterolemia in Nigeria: a 
systematic review and meta-analysis
Adeloye, D, Abaa, D Q, Owolabi, E O, Ale, B M, Mpazanje, R G, 
Dewan, M T, Omoyele, C, Ezeigwe, N, Alemu, W, Harhay, M O, 
Auta, Asa and Adewole, I F
Available at http://clok.uclan.ac.uk/30769/
Adeloye, D, Abaa, D Q, Owolabi, E O, Ale, B M, Mpazanje, R G, Dewan, M T, Omoyele, 
C, Ezeigwe, N, Alemu, W et al (2020) Prevalence of hypercholesterolemia in Nigeria: a 
systematic review and meta-analysis. Public Health, 178 . pp. 167-178. ISSN 0033-3506  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.1016/j.puhe.2019.09.002
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
1 
 
Prevalence of hypercholesterolemia in Nigeria: a systematic review 
and meta-analysis 
Davies Adeloye1,2*, Doofan Q Abaa1, Eyitayo O Owolabi3, Boni Maxime Ale4,5, 
Rex G Mpazanje6, Mary T Dewan6, Chiamaka Omoyele7, Nnenna Ezeigwe7, 
Wondimagegnehu Alemu8, Michael O Harhay9,10, Asa Auta11, Isaac F Adewole7 
1. Centre for Global Health Research, Usher Institute, University of Edinburgh, UK. 
2. RcDavies Evidence-based Medicine, Lagos, Nigeria 
3. Department of Nursing Sciences, University of Fort Hare, East London, South Africa 
4. Institut national de la santé et de la recherche médicale (INSERM), Paris, France 
5. Holo Healthcare Limited, Nairobi, Kenya 
6. WHO Nigeria Country Office, Abuja, Nigeria 
7. Federal Ministry of Health, Abuja, Nigeria  
8. International Health Consultancy, LLC, Atlanta, Georgia, USA 
9. Department of Biostatistics, Epidemiology and Informatics, Perelman School of 
Medicine University of Pennsylvania Philadelphia, Pennsylvania, USA 
10. Palliative and Advanced Illness Research (PAIR) Center, Perelman School of 
Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA 
11. School of Pharmacy and Biomedical Sciences, University of Central Lancashire, 
Fylde Road, Preston, UK 
 
*Correspondence: Dr. Davies Adeloye, Centre for Global Health Research, Usher Institute, 
University of Edinburgh, 30 West Richmond street, EH8 9DX, email: 
Davies.Adeloye@ed.ac.uk 
Word count: 2786 
Tables: 5 
Figures: 5 
Acknowledgements: The authors acknowledge the support of the Nigeria Federal Ministry 
of Health and the WHO Nigeria Country Office in the conduct of this study. Special thanks to 
Victoria Nyawira Nyaga for checking through our statistical analyses. 
Authorship declaration: DA conceived and designed the study. DA, DQA and AA conducted 
the literature searches and data extraction. DA, DQA and EOO wrote the first draft. DA and 
MBA conducted the analysis. DA, AA, RGM, MTD, CO, NE, MOH, WA and IFA contributed to 
the final draft and checked for important intellectual content. All authors approved the 
manuscript as submitted. 
Disclosure statement: The authors declare no conflicts of interest. 
Funding: MOH is supported by a grant (K99HL141678) from the NIH/National Heart, Lung, 
and Blood Institute (NHLBI) 
Ethical approval: Not required. This paper was based on publicly available sources and data. 
 
2 
 
ABSTRACT 
Objectives: Elevated blood cholesterol (hypercholesterolemia) is a significant cause of 
cardiovascular disease. We aimed to estimate national and zonal prevalence of 
hypercholesterolemia in Nigeria to help guide targeted public health programs. 
Design: This is a systematic review and synthesis of publicly available epidemiologic data on 
hypercholesterolemia in Nigeria. 
Methods: We systematically searched MEDLINE, EMBASE, Global Health, and Africa Journals 
Online for studies on the prevalence of hypercholesterolemia in Nigeria published between 1990 
and 2018. We used a random-effects meta-analysis (Freeman-Tukey double arscine 
transformation) and meta-regression model to estimate the prevalence of hypercholesterolemia 
in Nigeria in 1995 and 2015. 
Results: 13 studies (n=16981) were retrieved. The pooled crude prevalence of 
hypercholesterolemia in Nigeria was 38% (95% CI: 26-51), with prevalence in women slightly 
higher (42%, 23-63) compared to men at (38%, 20-58). The prevalence was highest in the 
South-south (53%, 38-68) and lowest in the South-west (3%, 2-4) and North-east (4%, 2-7). 
Urban dwellers had a significantly higher rate (52%, 24-79) compared to rural dwellers (10%, 6-
15). We estimated over 8.2 million persons (age-adjusted prevalence 16.5%) aged 20 years or 
more had hypercholesterolemia in Nigeria in 1995, increasing to 21.9 million persons (age-
adjusted prevalence 25.9%) in 2015. 
Conclusions: Our findings suggest a high prevalence of hypercholesterolemia in Nigeria. 
Urbanization, lifestyles, diets, and culture appear to be driving an increasing prevalence, 
especially among women. Population-wide awareness and education on reducing elevated 
cholesterol levels and associated risks should be prioritised. 
Keywords: hypercholesterolemia; dyslipidaemia; prevalence; ischemic heart disease; Nigeria 
 
HIGHLIGHTS 
 Urbanization, with changing lifestyles, diets and culture, appear to be driving an 
increasing prevalence of hypercholesterolemia in Nigeria, particularly among women; 
 In 1995, over 8.2 million persons aged 20 years or more had hypercholesterolemia in 
Nigeria; 
 This increased by about 170% to 21.9 million persons in 2015. 
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INTRODUCTION 
Elevated blood cholesterol (hypercholesterolemia) is a leading cause of disease burden, 
accounting for one-third of ischemic heart disease and one fifth of stroke1, 2. In 2015, 
hypercholesterolemia resulted in 4.5% and 2% of global deaths and disability-adjusted life years 
(DALYs), respectively 3. Recent reports reveal a rising prevalence across many low- and 
middle-income countries, including Nigeria, with a quarter of adults affected 3. 
The rising burden of hypercholesterolemia in Nigeria corresponds with increasing rates of 
unhealthy diets and lifestyles in the population. A key driver of this is  urbanization, and the 
corresponding expansion of processed food outlets in the country4, 5. Further, reports suggest 
that major cooking oils in the country are high in saturated fats, and these are often unbranded 
or content not displayed6. Though, even if this information was better reported, many people do 
not check fats or cholesterol content of cooking oils, due to limited population-wide information 
and awareness on associated risks6. There is also evidence of a growing number of Nigerians 
with sub-optimal levels of physical activity3, 7, another driver of poor cholesterol management. 
Yet public health responses are largely absent across many settings 8. Epidemiologic studies 
are few, thus limiting a precise understanding of the burden 8, 9. Thus, we systematically 
searched and synthesized available data to estimate the national and zonal prevalence of 
hypercholesterolemia in Nigeria. Our primary goal is to raise awareness regarding this burden 
and to prompt relevant policy response and measures across the country. 
 
METHODS 
Search strategy 
We searched MEDLINE, EMBASE, Global Health, and Africa Journals Online (AJOL), for 
studies on hypercholesterolemia or dyslipidemia in Nigeria using the search terms shown in 
Table 1. Searches were conducted on 01 August 2018 and limited to studies published after 1 
January 1990. Unpublished documents were sourced from Google Scholar and Google 
searches. Titles and abstracts of studies were reviewed, and the full-text of relevant studies 
accessed. The reference lists of accessed full-texts were further hand-searched for additional 
studies. We contacted authors of selected papers for any missing information. 
Selection criteria 
We selected population- or hospital-based studies reporting on the prevalence of 
hypercholesterolemia in a Nigerian setting. However, due to the high number of studies on 
cardio-metabolic risks identified from an initial scoping exercise reporting on cholesterol levels 
or any form of dyslipidemia, we also carefully reviewed several studies on NCDs risks in Nigeria 
and extracted data on hypercholesterolemia or population lipid levels from such studies when 
reported. We excluded studies on Nigerians in diaspora, reviews, case reports, viewpoints, and 
commentaries. 
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Case definitions 
We checked for studies that defined hypercholesterolemia as elevated blood levels of total 
cholesterol, high low-density lipoprotein (LDL)-cholesterol, or high non-high-density lipoprotein 
(HDL)-cholesterol (which is the subtraction of HDL-cholesterol from total cholesterol)3. Some 
studies were based on dyslipidemia (i.e., abnormal lipid levels), as elevated cholesterol levels 
may be accompanied by a decrease in HDL-cholesterol or an increase in triglycerides. Hence, 
we also checked for studies that provided numerical estimates on elevated plasma cholesterol, 
triglycerides, or a low HDL cholesterol level, which satisfies a working definition of dyslipidemia 
3. However, to limit heterogeneity resulting from different case definitions in our analysis, we 
applied the United States National Heart, Lung, and Blood Institute recommended diagnostic 
criteria for hypercholesterolemia or dyslipidemia10 in our quality checks as follows: i) total 
cholesterol ≥200 mg/dl (5.2 mmol/l); ii) LDL-cholesterol ≥130 mg/dl (3.4 mmol/l); iv) HDL-
cholesterol ≤40mg/dl (1.0 mmol/l); or v) triglyceride ≥150 mg/dl (1.7 mmol/l) . We included any 
studies that reported estimates based on these diagnostic criteria. 
Data extraction 
Assessment of eligible studies was conducted independently by two reviewers (DA and AA), 
with an eligibility guideline to ensure that consistent selection criteria were applied. Any 
disagreement in study selection was resolved by consensus. Data on the location, study period, 
study design, study setting (urban or rural), sample size, diagnostic criteria, and mean age of 
the population were extracted. These were matched with corresponding data on persons with 
hypercholesterolemia, sample population, the prevalence of hypercholesterolemia in each 
study.  For studies conducted on the same study site, population or cohort, the first published 
study was selected, and all additional data from the other studies were extracted and merged 
with data from the selected paper.  
Quality assessment 
For each full text selected, we further screened for an explicit description of methodology, case 
definitions, and generalizability of reported estimates to a larger population within the geo-
political zone. For quality grading, we adapted a previously used quality assessment criteria for 
studies examining the prevalence of chronic diseases 11-14. For each full text selected, we 
screened for sampling strategy (was it representative of a target subnational population?), 
statistical methods (was it appropriate for the study outcome?), and case ascertainment (was it 
based on standard diagnostic criteria, unspecified clinical criteria, informant interviews, or not 
reported?). Studies were graded as high (4-5), moderate (2-3), or low quality (0-1) (see Tables 
2 and 3, for details of all full-text manuscripts accessed and quality grading).  
Data Analysis 
A random-effects meta-analysis was employed to generate national and sub-national estimates 
of the prevalence of hypercholesterolemia and mean cholesterol levels in Nigeria, using the 
Freeman-Tukey double arscine transformation 15 to normalize data given the wide variation in 
extracted crude estimates from studies. Standard errors were determined from the reported 
crude estimates and population denominators, assuming a binomial (or Poisson) distribution. 
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Heterogeneity between studies was assessed using I-squared (I2) statistics. Publication bias 
was assessed using Egger’s regression test for funnel plot asymmetry 16. A meta-regression 
model based on mean age from each study and adjusted for the study period was developed to 
determine prevalence distribution of hypercholesterolemia by the age of the Nigerian population 
over two separate years. As explained in previous studies 17, 18, we tested various models 
(linear, exponential, polynomial, logarithmic, etc.) to determine which was most predictive, 
representing the greatest proportion of variance(R2) of the prevalence of hypercholesterolemia 
as explained by the inputted variables. The equation of the model was used to generate age-
adjusted prevalence of hypercholesterolemia, at midpoints of 5–year age groups (ie. from 20–24 
(22), 25–29 (27), 30-34 (32), to 80 years and over). The age-adjusted prevalence for each year 
was multiplied by the corresponding United Nation (UN) population for Nigeria (by 5-year age 
group) 19 to estimate the absolute number of persons with hypercholesterolemia in Nigeria for 
the years 1995 and 2015. All statistical analyses were conducted in Stata (Stata Corp V.14, 
Texas, USA). The study was guided by the PRISMA checklist 20. 
RESULTS 
Search results 
The databases’ searches returned 496 studies (MEDLINE 192, EMBASE 261, Global Health 34, 
and AJOL 9). An additional 11 studies were identified through Google Scholar, and hand-
searching reference lists of relevant studies. After duplicates have been removed, 322 titles 
were screened for relevance (i.e. any epidemiologic studies on hypercholesterolemia in 
Nigeria). On applying the selection criteria, 261 studies were excluded. Hence, 61 full-texts were 
assessed and further screened comprehensively using the pre-designed selection and quality 
criteria. Forty-eight studies were then excluded at this stage. We finally included 13 studies 21-33 
for both quantitative and qualitative synthesis (Figure 1). 
Study Characteristics 
The 13 studies covering a population of 16981 were selected across the southern and northern 
parts of Nigeria, with only the North-western geopolitical zone not represented (Table 3). There 
were five studies from the South-south, four from the South-east, two from the North-central, 
and one study each from the North-east and South-west. Although most studies were 
conducted outside hospital settings, they may not be entirely referred as population-based, as 
some studies were limited to specific population groups, including professionals, civil servants, 
university employees, with a total population of 16,981. Most studies mainly presented 
prevalence estimates for hypercholesterolemia (expressed as the proportion of the population 
with total cholesterol ≥200 mg/dl or 5.2 mg/dl). Hence this was the only pooled prevalence rate 
reported in this study. However, as mean blood cholesterol levels were reported across studies, 
we pooled nation-wide blood levels of total cholesterol LDL-cholesterol, HDL-cholesterol and 
triglycerides. Six (6) studies were conducted in urban settings, four (4) in semi-urban settings 
(i.e. a mix of urban and rural dwellers), and three (3) in rural settings. Study period ranged from 
1992 to 2015, with most studies conducted within a one-year period. The aggregated mean age 
from all studies ranged from 22 to 65 years (Table 3). Although five studies were rated as high 
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quality, heterogeneity was high across studies (I-squared (I2)=99.6%, P≤0.001) and funnel plot 
was asymmetrical suggesting publication bias (Egger’s test (z)=1.67, P=0.008) (Figure 2). 
Prevalence of hypercholesterolemia in Nigeria 
The highest prevalence of hypercholesterolemia was reported among staffs of a higher 
education institution in Owerri, Imo State, South-east Nigeria at 91.3% 22. Other high estimates 
of hypercholesterolemia were reported among elderly urban residents in Asaba, Delta State, 
South-south Nigeria (70.0%) 25, and in another higher education community in Jos, Plateau 
State, North-central Nigeria (51.8%) 21. The lowest prevalence of hypercholesterolemia was 
reported in Egbeda, a rural town in Oyo State, South-west Nigeria, at 3.2% 24. There were also 
some low prevalence rates of hypercholesterolemia estimated in two separate sites in Imo 
State, South-east Nigeria, at 7.8% and 8.2% 32, 33 (Table 3). Across all data-points, the pooled 
crude prevalence of hypercholesterolemia in Nigeria was 38% (95% CI: 26-51). (Figure 3). 
When estimates from population-based studies were considered, the pooled prevalence was 
33% lower, though the confidence interval were wide  (95% CI: 9-62). The prevalence in women 
was higher at 42% (95% CI: 23-63) than estimated among men at 38% (95% CI: 20-58) 
(Figures 4 & 5, Table 4). Across the geo\political zones, the prevalence of 
hypercholesterolemia was highest in the South-south at 53% (95% CI: 38-68), followed by 
North-central (36%, 95% CI: 34-38) and South-east (34%, 95% CI: 14-58). The South-west 
(3.2%, 95% CI: 2-4) and the North-east (4%, 95% CI: 2-7) had the lowest estimated prevalence 
rates. The distribution of the prevalence of hypercholesterolemia across study settings suggest 
a significantly higher rate in urban settings at 52% (95% CI: 24-79), compared to rural settings 
at 10% (95% CI: 6-15) (Table 4). See supplementary material for detailed sex variation across 
study design, setting and geopolitical zone. 
Pooled blood lipid levels in Nigeria 
The pooled mean total cholesterol concentration in Nigeria is approaching the borderline high 
levels, with an upper limit reaching the borderline (189.1m mg/dl, 95% CI: 177.6-200.7). The 
pooled mean concentration of LDL-cholesterol was 100.4 mg/dl (95% CI: 65.6-131.2), which 
can be regarded as good, but also with an upper limit above the borderline high levels.  We 
estimated a nation-wide mean HDL-cholesterol concentration at 61.8 mg/dl (95% CI: 50.2-73.3) 
which is in the range of the accepted levels needed to lower cardiovascular disease risk. The 
estimated pooled triglycerides concentration may also be regarded as acceptable at 132.8 mg/dl 
(95% CI: 97.4-159.3), although as observed with total cholesterol and LDL-cholesterol, the 
upper limit is above normal.  
Estimated number of persons with hypercholesterolemia in Nigeria 
Age-adjusted prevalence of hypercholesterolemia increased as the population ages, P=0.012 
(see supplementary material for meta-regression model). Using the United Nations 
demographic projections for Nigeria, and based on an assumption that our extracted dataset 
was collected between 1992 and 2015 (see study period in Table 3), we estimated over 8.2 
million persons (17%) aged 20 years or more with hypercholesterolemia in Nigeria in 1995.  By 
2015, cases of hypercholesterolemia have increased by about 166% to 21.9 million persons 
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(26%) in the same age group. Although, it appears the rapid population and demographic 
changes in Nigeria over this 20-year period were partly responsible for this increase (Table 5). 
DISCUSSION 
In this study, we sought to estimate the number of individuals living with elevated blood 
cholesterol levels in Nigeria. We estimate that the age-adjusted prevalence of 
hypercholesterolemia increased from 17% to 26% among persons aged 20 years or more 
between 1995 and 2015. In 1992, Akinkugbe and Akinkanju 34 estimated a nation-wide 
prevalence of hypercholesterolemia at 4%. Though there is not yet another national estimate, a 
number of community-based studies conducted across the country independently suggest an 
increasing prevalence, with estimates ranging from 27-52% across different population groups 4, 
8, 9, 35. When compared with the WHO African region, our 2015 estimate is slightly higher (26% 
versus 23%), although still lower than the global prevalence at 39% 3. Moreover, we reported a 
near-borderline population mean total cholesterol at 189 mg/dl. While mean total cholesterols 
may not be key indicators of the distribution of hypercholesterolemia in a population 36, a co-
existing high and rising prevalence imply a need for more comprehensive population-wide 
measures to prevent health consequences. 
In this study, we found a slightly higher hypercholesterolemia prevalence among women 
compared to men in Nigeria. This difference has also been documented in previous studies 1, 36, 
however the higher rate among women in Nigeria is largely connected to less physical activity 
and an increasing patronage of processed food outlets 34, 37. Reports suggest some women 
adopt this lifestyle to add weight, as this indicates higher social class and better living standards 
38, 39.  Other factors thought to be influencing the higher prevalence of hypercholesterolemia in 
females include gender roles and religious expectations. In many Nigerian settings, women are 
required to primarily stay indoors and complete domestic chores, with this predisposing women 
to higher caloric intake and sedentary lifestyles 38. 
Our study sought to provide the first zonal estimates of hypercholesterolemia across Nigeria.  
Though these are marked by wide uncertainties, the highest prevalence was reported in the 
South-south at 53%.  Some authors have noted that dyslipidemia was highly prevalent across 
all geopolitical zones in Nigeria, although Southern ethnic groups whose typical diet contained 
higher fat contents had significantly higher total blood cholesterol levels 8, 40. It is likely that the 
relatively higher socio-economic status in these settings could partly drive elevated blood 
cholesterol levels, as a positive correlation between hypercholesterolemia and wealth index is 
well-documented 35, 36, 41.  As the southern parts of Nigeria are experiencing faster rates of 
urbanization, the higher rates of hypercholesterolemia in these settings could be explained. 
Venkichatalam and colleagues 1 reported that observed elevated cholesterol levels across world 
regions vary with national and sub-national economic developments.  
Although urbanization, lifestyles, and diets are believed to be leading causes of raised 
cholesterol levels in Nigeria, culture, ethnic diversities, literacy levels and lack of information 
also play important roles, and should be considered in preventive measures 35, 42. In three 
studies conducted across southern and northern Nigeria, several participants reported being 
unaware of the risks of abnormal lipid patterns and a need for lipid profile and screening 35, 42, 43. 
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In many parts of the country, the quantity and type of food consumed, and where they are 
purchased, can contribute to social status 44.  
Though there is robust evidence linking early identification and treatment of 
hypercholesterolemia with reduced cardiovascular morbidity and mortality 45, 46, interventions 
targeting hypercholesterolemia in Nigeria are limited. Although the management of elevated 
blood cholesterol and other cardiovascular risks may be complex at the country level 1, the 
challenges are worsened in Nigeria due to poor understanding of the burden, limited research, 
varying guidelines, complex prescriptions, and several health system challenges 1. Across many 
health centres, hypercholesterolemia is an incidental clinical finding, and patients appear to be 
unwilling to incur high out-of-pocket expenses on lipid-lowering therapy as part of the 
management of other ailments 5, 6, 47. Clinicians have advocated for more awareness and 
government response to complement treatment efforts 5, 47 
Our study has some limitations. First, there was a limited number of epidemiologic reports on 
high blood lipids in Nigeria, and studies appear to be poorly conducted, with only five studies 
rated as high quality. In addition, we could only retrieve studies from five of the six geopolitical 
zones in Nigeria, with no studies providing information regarding populations from the North-
west. This covers seven states, accounting for about 25% of Nigeria’s population. Second, 
heterogeneity was high across studies, reflecting varying study designs, case ascertainment, 
and the population covered—limited to specific groups including university employees, 
professionals and civil servants in some studies. Third, although we ensured hospital-based 
studies were from outpatient settings with a well-defined catchment population, our 
denominators could have been under-reported, thus presenting with higher estimates from 
hospital-based studies (41%) compared to population-based studies (33%), possibly affecting 
our overall estimates (38%). Moreover, the different contexts under which these studies were 
designed are important sources of heterogeneity and indeed affect overall representativeness of 
our estimates. These are important considerations in the interpretation of our findings. Albeit, we 
have provided important datasets and estimates relevant that can support and motivate further 
research and necessary policy interventions. 
CONCLUSION 
Our findings suggest a high prevalence of hypercholesterolemia in Nigeria. Urbanization, 
lifestyles, diets, and culture appear to be driving an increasing prevalence, especially among 
women. Population response and clinical management have been sub-optimal. Population-wide 
awareness and education on elevated cholesterols and associated risks should be prioritized 
among other interventions.  
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FIGURE 1. Flow chart of selection of studies on hypercholesterolemia in Nigeria. 
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FIGURE 2. Funnel plot showing distribution of selected studies 
 
Egger’s test (z) = -1.67, P = 0.008. 
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FIGURE 3. Plate A. Pooled rate of hypercholesterolemia in Nigeria, by geopolitical zone.  
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FIGURE 3. Plate B. Pooled rate of hypercholesterolemia in Nigeria, by study design.  
 
 
 
 
 
16 
 
FIGURE 3. Plate C. Pooled rate of hypercholesterolemia in Nigeria, by study setting. 
 
 
 
 
17 
 
FIGURE 4. Pooled rate of hypercholesterolemia in Nigeria, men. 
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FIGURE 5. Pooled rate of hypercholesterolemia in Nigeria, Women. 
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TABLE 1. Search terms on hypercholesterolemia in Nigeria 
# Searches 
1 africa/ or africa, sub-sahara/ or africa, western/ or 
nigeria/  
2 exp vital statistics/   
3 (incidence* or prevalence* or morbidity or 
mortality).tw.  
4 (disease adj3 burden).tw.  
5 exp "cost of illness"/  
6 case fatality rate.tw 
7 hospital admissions.tw 
8 Disability adjusted life years.mp.  
9 (initial adj2 burden).tw.  
10 exp risk factors/  
11 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10  
12 exp dyslipidemia / or abnormal lipids / or abnormal 
cholesterol / or hypercholesterolemia /or elevated 
cholesterol 
13 1 and 11 and 12  
14 Limit 13 to “1990-current” 
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TABLE 2. Quality assessment of selected studies 
Quality criteria Assessment Score Maximum score 
Sampling method (was 
it representative of a 
target subnational 
population?) 
Yes 1 1 
No 0 
Appropriateness of 
statistical analysis 
Yes 1 1 
No 0 
Case ascertainment 
(was it based on 
standard diagnostic 
criteria, other criteria or 
case definition, unclear, 
or not reported?) 
Standard diagnostic 
criteria 
3 3 
Other criteria  2 
unclear  1 
Not-reported 0 
Total (high (4-5), moderate (2-3), or low quality (0-1)) 5 
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TABLE 3. Characteristics of studies on prevalence of hypercholesterolemia in Nigeria 
Author Study 
Perio
d 
Location Geopolit
ical 
zone 
Study design Study 
Settin
g 
Me
an 
ag
e 
(ye
ars
) 
Sa
mp
le 
Prev
alenc
e (%) 
Qua
lity 
Agaba et 
al 21 
2014 Jos, 
Plateau 
State 
North-
central 
Population-based Urban 44 883 51.8 High 
Emerole et 
al 22 
2007 Owerri, 
Imo State 
South-
east 
Descriptive cross-
sectional study 
Urban 53 241 91.3 Mod
erat
e 
Ugwuja et 
al 23 
2008 Abakaliki, 
Ebonyi 
State 
South-
east 
Descriptive cross-
sectional study 
Urban 40.
9 
205 37.1 Mod
erat
e 
Oladapo et 
al 24 
2005 Egbeda, 
Oyo State 
South-
west 
Population-based Rural 42.
1 
200
0 
3.2 Mod
erat
e 
Odenigbo 
et al 25 
2009 Asaba, 
Delta State 
South-
south 
Hospital-based Urban 67 176 69.9 Mod
erat
e 
Okaka & 
Eiya 26 
2013 Ovia, Edo 
state 
South-
south 
Hospital-based Rural 48 161 31.7 Mod
erat
e 
Odenigbo 
et al 27 
2008 Asaba, 
Delta State 
South-
south 
Population-based Mixed 41.
6 
100 23.0 Mod
erat
e 
Oyeyemi & 
Adeyemi 28 
2013 Maiduguri, 
Borno 
State 
North-
east 
Population-based 
cross-sectional 
study 
Mixed 44.
9 
292 6.8 High 
*Forrest et 
al 29 
1992 Benin, Edo 
State 
South-
south 
Population-based 
cross-sectional 
study 
Urban 41.
1 
799 - High 
Oguoma et 
al 30 
2015 Kwale, 
Delta State 
South-
south 
Population-based  
cross-sectional 
study 
Mixed 39.
9 
422 38.1 High 
Ojji et al 31 2010 Abuja, 
FCT 
North-
central 
Hospital-based Urban 49 913 22.5 High 
22 
 
Iloh et al 32 2009 Imo State South-
east 
Hospital-based Rural 40 215
6 
7.8 Mod
erat
e 
Iloh et al 33 2008 Imo State South-
east 
Hospital-based Semi-
Urban 
37 929
6 
8.2 Mod
erat
e 
*study reported only blood lipid levels. 
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Table 4. Pooled estimates of hypercholesterolemia and blood lipid levels in Nigeria 
Region Both sexes Men Women 
Prevalence % 
(95% CI) 
I2, P-
value 
Prevalence 
% (95% CI) 
I2, P-
value 
Prevalence 
% (95% CI) 
I2, P-
value 
Nation-wide 38 (26-51) 99.5, 
<0.001 
38 (20-58) 98.8, 
<0.001 
42 (23-63) 98.7, 
<0.001 
Study 
design 
Population-
based 
33 (9-62) 99.7, 
<0.001 
18 (2-46) 99.3, 
<0.001 
23 (3-54) 99.3, 
<0.001 
Hospital-
based 
41 (29-55) 99.1, 
<0.001 
58 (29-85) 97.1, 
<0.001 
62 (34-86) 94.5, 
<0.001 
Settings Urban 52 (24-79) 99.4, 
<0.001 
34 (32-37) 0.0 37 (34-41) 0.0 
Rural 10 (6-15) 98.0, 
<0.001 
3 (2-4) - 3 (2-4) - 
Semi-
urban 
48 (25-71) 98.3, 
<0.001 
46 (19-74) 97.7, 
<0.001 
50 (30-70) 93.9, 
<0.001 
Geopolitical 
zone 
North-
central 
36 (34-38) 0.0 34 (32-37) 0.0 37 (34-41) 0.0 
North-east 4 (2-7) - 2 (1-5) - 9 (5-16_ - 
South-east 34 (14-58) 94.6, 
<0.001 
- - - - 
South-
south 
53 (38-68) - 56 (37-73) 91.8, 
<0.001 
57 (40-73) 86.6, 
<0.001 
South-west 3 (2-4) - 3 (2-4) - 3 (2-4) - 
Pooled blood lipid levels 
Lipid type Concentration 
(mg/dl; 
mmol/l) 
I2, P-
value 
- - - - 
Total cholesterol 189.1 (177.6-
200.7); 4.9 
(4.6-5.2) 
0.0, 
0.808 
- - - - 
LDL-cholesterol 100.4 (65.6-
131.2); 2.6 
(1.7-3.4) 
77.7, 
<0.001 
- - - - 
HDL-cholesterol 61.8 (50.2-
73.3); 1.6 (1.3-
24.0, 
0.254 
- - - - 
24 
 
1.9) 
Triglycerides 132.8 (97.4-
159.3); 1.5 
(1.1-1.8) 
0.0, 
0.743 
- - - - 
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TABLE 5. Absolute number of persons with hypercholesterolemia in Nigeria, aged 20 
years or more, 1995 and 2015 
Age 
(years)  
1995 2015 
Prevalence 
(%) 
Population 
(000) 
Cases 
(000) 
Prevalence 
(%) 
Population 
(000) 
Cases 
(000) 
20-24 0.1 9732.1 4.4 3.9 15981.8 636.5 
25-29 0.8 7814.7 61.1 10.7 14051.0 1497.6 
30-34 5.9 6586.9 388.2 17.3 12102.3 2097.7 
35-39 12.6 5534.3 695.6 24.0 9982.6 2396.6 
40-44 19.2 4611.6 887.4 30.7 7767.7 2383.4 
45-49 25.9 3894.2 1009.3 37.4 6008.7 2244.7 
50-54 32.6 3330.8 1085.6 44.0 4993.8 2198.9 
55-59 39.3 2690.9 1056.7 50.7 4146.1 2102.4 
60-64 45.9 2090.9 960.6 57.4 3325.7 1908.4 
65-69 52.6 1544.5 812.7 64.1 2554.2 1636.2 
70-74 59.3 1031.8 611.8 70.7 1821.5 1288.4 
75-79 66.0 581.5 383.6 77.4 1077.6 834.2 
80+ 76.6 353.3 270.8 88.1 721.8 635.8 
All 16.5 49797.6 8227.7 25.9 84534.9 21860.8 
Note: Estimates based on the epidemiologic model (y=1.335x+0.573t-1178.246). Where y=prevalence of 
hypercholesterolemia, x=age, and t=year. Coefficients of ‘x’ and ‘t’ are ‘1.335ʹ and ‘0.573ʹ for the meta-
regressed line, with an intercept of ‘-1178.246ʹ 
 
 
 
 
